在狂妄症中睡眠-觉醒障碍的药理学管理
Erik A Levinsohn1,2, Varsha Radhakrishnan3,4, Haley Euting5,6
1Department of Psychiatry, University of California San Francisco Medical Center, San Francisco, CA, USA.
Journal of clinical pharmacology
|October 17, 2024
概括
睡眠障碍在妄想中很常见. 本综述检查了像黑激素和德克斯梅德托米丁这样的药物用于管理与妄想有关的睡眠问题,并提供了潜在的治疗选择.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 睡眠医学 睡眠医学
背景情况:
- 妄想是一种注意力和意识变化的综合征.
- 睡眠-觉醒障碍,包括昼夜节律逆转和碎片化睡眠,是妄想症的标志性特征.
- 睡眠障碍和妄想之间的关系往往是相互的,并且可能有共同的起源.
研究的目的:
- 审查用于妄相关睡眠障碍的药物的药理学和药理动力学.
- 探索有关黑激素,拉梅尔,双素受体对抗剂 (DORAs) 和德克斯梅德托米丁在治疗痴呆症和相关睡眠问题的证据.
- 为了告知临床决策,关于药理干预的睡眠-清醒周期干扰在痴呆症.
主要方法:
- 对研究的文献综述,研究了在狂妄症中使用特定药物的研究.
- 对审查药物的药理动力学和药理动力学特性进行分析.
- 综合当前关于选择药物疗法的有效性和安全性的证据.
主要成果:
- 黑色素和拉梅尔对妄相关的睡眠障碍有潜在的益处.
- 德克斯梅德托米丁可能对患有妄想症的重症监护室 (ICU) 患者有益.
- 在妄症中,DORAs为重新调节睡眠和清醒周期提供了治疗选择.
结论:
- 虽然非药物干预是首要的,但对于妄相关的睡眠障碍,某些药物需要考虑.
- 了解药物的药理动力学和药理动力学对于优化治疗至关重要.
- 需要进一步的研究,以建立药理管理的最终治疗指南.
相关概念视频
01:19Management of Insomnia
234
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
234
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
149
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
149
01:23Sedatives and Hypnotics: Overview
286
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
286
01:15REM Sleep Behavior Disorder
158
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
158
01:26Psychosis: Goals of Pharmacotherapy
109
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
109
01:14CNS Depressants: Barbiturates and Benzodiazepines
230
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
230